Modulation of neural activation following treatment of hepatic encephalopathy

Neurology

Volumn 80, Issue 11, 2013, Pages 1041-1047

  McPhail, Mark J W ^a   Leech, Robert ^a   Grover, Vijay P B ^a   Fitzpatrick, Julie A ^a,b   Dhanjal, Novraj S ^a   Crossey, Mary M E ^a   Pflugrad, Henning ^a   Saxby, Brian K ^c   Wesnes, Keith ^d   Dresner, M Alex ^b   Waldman, Adam D ^b   Thomas, Howard C ^a   Taylor Robinson, Simon D ^e  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b MRC CLINICAL SCIENCES CENTRE   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d UNITED BIOSOURCE CORPORATION   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; ORNITHINE;

ADULT; ARTICLE; BASAL GANGLION; BLOOD OXYGENATION; BRAIN NERVE CELL; BRAIN SIZE; CELL ACTIVATION; CLINICAL ARTICLE; COGNITION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MALE; POSTERIOR CINGULATE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOMETRY; VISUAL CORTEX; VISUOMOTOR COORDINATION;

EID: 84876217309     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31828726e1     Document Type: Article

References (39)

1. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716-721.
2. Dhiman RK, Chawla YK. Minimal hepatic encephalopathy: time to recognise and treat. Trop Gastroenterol 2008; 29:6-12.
3. Bajaj JS, Hafeezullah M, Hoffmann RG, Saeian K. Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations. Am J Gastroenterol 2007;102:1903-1909.
4. Tan HH, Lee GH, Thia KT, Ng HS, Chow WC, Lui HF. Minimal hepatic encephalopathy runs a fluctuating course: results from a three-year prospective cohort follow-up study. Singapore Med J 2009;50:255-260.
5. Amodio P, Schiff S, Del Piccolo F, Mapelli D, Gatta A, Umilta C. Attention dysfunction in cirrhotic patients: an inquiry on the role of executive control, attention orienting and focusing. Metab Brain Dis 2005;20:115-127.
6. Bajaj JS, Hafeezullah M, Franco J, et al. Inhibitory Control Test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology 2008;135:1591-1600.e1.
7. Bajaj JS, Hafeezullah M, Hoffmann RG, et al. Navigation skill impairment: another dimension of the driving difficulties in minimal hepatic encephalopathy. Hepatology 2008;47:596-604.
8. Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001;34:768-773.
9. Mardini H, Saxby BK, Record CO. Computerized psychometric testing in minimal encephalopathy and modulation by nitrogen challenge and liver transplant. Gastroenterology 2008;135:1582-1590.
10. Gotman J, Grova C, Bagshaw A, Kobayashi E, Aghakhani Y, Dubeau F. Generalized epileptic discharges show thalamocortical activation and suspension of the default state of the brain. Proc Natl Acad Sci USA 2005;102:15236-15240.
11. Tian L, Jiang T, Wang Y, et al. Altered resting-state functional connectivity patterns of anterior cingulate cortex in adolescents with attention deficit hyperactivity disorder. Neurosci Lett 2006;400:39-43.
12. Rombouts SA, Barkhof F, Goekoop R, Stam CJ, Scheltens P. Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI study. Hum Brain Mapp 2005;26:231-239.
13. Kinnunen KM, Greenwood R, Powell JH, et al. White matter damage and cognitive impairment after traumatic brain injury. Brain 2011;134:449-463.
14. Zhang LJ, Yang G, Yin J, Liu Y, Qi J. Neural mechanism of cognitive control impairment in patients with hepatic cirrhosis: a functional magnetic resonance imaging study. Acta Radiol 2007;48:577-587.
15. Zhang LJ, Yang G, Yin J, Liu Y, Qi J. Abnormal default-mode network activation in cirrhotic patients: a functional magnetic resonance imaging study. Acta Radiol 2007;48:781-787.
16. Poo JL, Gongora J, Sanchez-Avila F, et al. Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy: results of a randomized, lactulose-controlled study. Ann Hepatol 2006;5:281-288.
17. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-649.
18. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-470.
19. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(suppl 1): S208-S219.
20. Haussinger D. Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology 2006;43:1187-1190.
21. Shawcross DL, Wright G, Olde Damink SW, Jalan R. Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab Brain Dis 2007;22:125-138.
22. Ahboucha S, Butterworth RF. The neurosteroid system: implication in the pathophysiology of hepatic encephalopathy. Neurochem Int 2008;52:575-587.
23. Ahboucha S, Butterworth RF. Role of endogenous benzodiazepine ligands and their GABA-A-associated receptors in hepatic encephalopathy. Metab Brain Dis 2005;20: 425-437.
24. Als-Nielsen B, Koretz RL, Kjaergard LL, Gluud C. Branched-chain amino acids for hepatic encephalopathy. Cochrane Database Syst Rev 2003:CD001939.
25. Patel N, White S, Dhanjal NS, Oatridge A, TaylorRobinson SD. Changes in brain size in hepatic encephalopathy: a coregistered MRI study. Metab Brain Dis 2004;19:431-445.
26. Taylor-Robinson SD, Oatridge A, Hajnal JV, Burroughs AK, McIntyre N, deSouza NM. MR imaging of the basal ganglia in chronic liver disease: correlation of T1-weighted and magnetisation transfer contrast measurements with liver dysfunction and neuropsychiatric status. Metab Brain Dis 1995;10: 175-188.
27. Taylor-Robinson SD, Sargentoni J, Marcus CD, Morgan MY, Bryant DJ. Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy. Metab Brain Dis 1994;9:347-359.
28. Miese F, Kircheis G, Wittsack HJ, et al. 1H-MR spectroscopy, magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy. AJNR Am J Neuroradiol 2006;27:1019-1026.
29. Hagmann P, Cammoun L, Gigandet X, et al. Mapping the structural core of human cerebral cortex. PLoS Biol 2008; 6:e159.
30. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. A default mode of brain function. Proc Natl Acad Sci USA 2001;98:676-682.
31. Greicius MD, Kiviniemi V, Tervonen O, et al. Persistent default-mode network connectivity during light sedation. Hum Brain Mapp 2008;29:839-847.
32. Leech R, Kamourieh S, Beckmann CF, Sharp DJ. Fractionating the default mode network: distinct contributions of the ventral and dorsal posterior cingulate cortex to cognitive control. J Neurosci 2011;31:3217-3224.
33. Kelly AM, Uddin LQ, Biswal BB, Castellanos FX, Milham MP. Competition between functional brain networks mediates behavioral variability. Neuroimage 2008; 39:527-537.
34. Amodio P, Marchetti P, Del Piccolo F, et al. Visual attention in cirrhotic patients: a study on covert visual attention orienting. Hepatology 1998;27:1517-1523.
35. Zafiris O, Kircheis G, Rood HA, Boers F, Haussinger D, Zilles K. Neural mechanism underlying impaired visual judgement in the dysmetabolic brain: an fMRI study. Neuroimage 2004;22:541-552.
36. Reeves RR, Struve FA, Rash CJ, Burke RS. P300 cognitive evoked potentials before and after liver transplantation. Metab Brain Dis 2007;22:139-144.
37. Mayer AR, Mannell MV, Ling J, Gasparovic C, Yeo RA. Functional connectivity in mild traumatic brain injury. Hum Brain Mapp 2011;32:1825-1835.
38. Lockwood AH, Weissenborn K, Bokemeyer M, Tietge U, Burchert W. Correlations between cerebral glucose metabolism and neuropsychological test performance in nonalcoholic cirrhotics. Metab Brain Dis 2002;17:29-40.
39. Cagnin A, Taylor-Robinson SD, Forton DM, Banati RB. In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy. Gut 2006;55:547-553.